Item 8.01 Other Events.
In connection with the announcement by Transdel Pharmaceuticals, Inc. (the
"Company") of the top-line results of the Phase 3 clinical study of
KetotransdelŪ, the Company issued a press release on October 6, 2009. A copy of
this press release is included as Exhibit 99.1 to this Current Report on Form
8-K and is incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits
(d) Exhibits
Exhibit No. Description
99.1 Press Release of the Company, dated October 6, 2009.
Add
TDLP.OB to Portfolio
Set Alert
Email to a
Friend